Preserved Function of Endothelial Colony-Forming Cells in Female Rats with Intrauterine Growth Restriction:

Thea Chevalley1, Floriane Bertholet1, Marion Dübi1

  • 1DOHaD Laboratory, Department Woman-Mother-Child, Division of Pediatrics, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.

Cells
|January 28, 2026
PubMed

Insights

Female rats born after intrauterine growth restriction (IUGR) show subtle changes in endothelial progenitor cells (EPCs) without significant vascular damage. These minor ECFC alterations may protect against cardiovascular issues like high blood pressure.

Area of Science:

  • Cardiovascular research
  • Developmental biology
  • Cellular and molecular medicine

Background:

  • Intrauterine growth restriction (IUGR) increases offspring cardiovascular risk.
  • Endothelial progenitor cells (EPCs), especially ECFCs, are vital for vascular health.
  • IUGR males show vascular issues and ECFC dysfunction; females do not, posing a research question.

Purpose of the Study:

  • To investigate ECFCs and vascular function in female rats with IUGR.
  • To determine if ECFC dysfunction occurs without overt vascular alterations in IUGR females.

Main Methods:

  • Isolated and analyzed ECFCs from 6-month-old female IUGR and control rats.
  • Performed in vivo and in vitro vascular assessments, including pulse wave velocity and aortic tissue analysis.
  • Assessed ECFC markers, proliferation, capillary formation, nitric oxide pathway, oxidative stress, and senescence.

Main Results:

  • IUGR females had altered aortic collagen and elastin but normal pulse wave velocity.
  • IUGR ECFCs showed minor changes in progenitor marker CD34 and delayed proliferation but preserved capillary formation.
  • A trend towards reduced nitric oxide (NO) and endothelial nitric oxide synthase (eNOS) was observed; oxidative stress and senescence markers were unchanged.

Conclusions:

  • ECFCs from 6-month-old female IUGR rats exhibit only minor functional alterations.
  • These subtle ECFC changes may contribute to vascular protection against increased SBP, rarefaction, and stiffness in IUGR females.
  • Findings suggest sex-specific vascular adaptations in response to IUGR.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
595
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
464
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
495
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
612
Arteries of Lower Limbs01:20

Arteries of Lower Limbs

The external iliac artery transitions out of the body cavity, entering the femoral region of the lower leg, and is renamed the femoral artery at the point where it traverses the body wall. This artery is responsible for the distribution of blood to the thigh's deep muscles and the skin's ventral and lateral regions, achieved through several minor branches and the lateral deep femoral artery, which also spawns a lateral circumflex artery. The knee area receives blood from the genicular...
4.5K
Arteries and Arterioles01:16

Arteries and Arterioles

Arteries, the vasculature responsible for transporting blood from the heart, possess robust walls capable of enduring the elevated pressures exerted by the heartbeat. Arteries near the heart are especially thick-walled and enriched with elastic fibers across their three tunics, classifying them as elastic or conducting arteries. These arteries, usually with a diameter exceeding 10 mm, are characterized by their ability to dilate in response to the blood pumped from the heart's ventricles...
6.6K